Drugs / 3-2,4 dimethoxy-benzilidene anabaseine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00952393 | Jan 2010 → Oct 2014 | schizophrenia | VA Office of Research and Development | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3-2,4 dimethoxy-benzilidene anabaseine | “This single arm examines the pharmaco-kinetics of the release of 3-2,4 dimethoxy-benzilidene anabaseine in a hypomellose sustained release formulation.” NCT00952393 ↗ |